In these trying times, companies continue to look for new and innovative ways to reduce overhead, yet they are often unable to see some significant cost drivers.
In the workers' compensation arena, pharmaceutical costs continue to rise at an alarming pace. At the same time, there are fewer injured workers and shorter claim times. What can be done to reduce pharmaceutical spend among injured workers?
PMSI, Inc., of Tampa, a provider serving the workers' compensation and liability markets, has joined CompPharma, LLC. A national consortium of pharmacy benefit management (PBM) firms specializing in
PMSI, a specialty products and services provider for the workers' compensation market, announced the appointment today of Paul DiFrancesco as president of its Medical Services and Equipment division.
As the U.S. population continues to age, risk managers and their comp insurers can expect to face continuing increases in long-lasting and recurrent workplace injuries, driving up drug expenditures to treat them, according to an expert in the field.
The workers' compensation industry experienced a 5.4 percent growth in total pharmacy spend per injured worker in 2008, according to a study by Tampa, Fla.-based comp insurance services firm PMSI.
PMSI Settlement Solutions (formerly PMSI MSA Services) represents the expansion of MSA-related services. Dr. Kent Takemoto has been named president of the division. Jim Molloy has joined the firm as
Tampa, Fla.-based PMSI, a specialty services provider for the workers' compensation industry and liability markets, announced today that Eileen Auen is joining the company as chairman and chief execut